Defatting strategies in the current era of liver steatosis

被引：17

作者：

Mazilescu, Laura Ioana ^{[1
,2
,3
]}

Selzner, Markus ^{[1
]}

Selzner, Nazia ^{[1
]}

机构：

[1] Toronto Gen Hosp, Ajmera Transplant Program, Toronto, ON, Canada

[2] Hosp Sick Children, Div Nephrol, Toronto, ON, Canada

[3] Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany

来源：

JHEP REPORTS | 2021年 / 3卷 / 03期

关键词：

Macrosteatosis; ischemia-reperfusion injury; machine perfusion; liver transplantation; NONALCOHOLIC FATTY LIVER; HEPATIC STEATOSIS; CULTURED-HEPATOCYTES; MACHINE PERFUSION; LIPID-METABOLISM; PPAR-DELTA; TRANSPLANTATION; STEATOHEPATITIS; PRESERVATION; MACROSTEATOSIS;

D O I：

10.1016/j.jhepr.2021.100265

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Liver steatosis is emerging as a major cause of chronic liver disease worldwide, mainly due to the increasing rate of obesity, type 2 diabetes, and metabolic syndrome. Because of the increased incidence of liver steatosis, many organs are currently declined for transplantation despite high demand and waiting list mortality. Defatting strategies have recently emerged as a means of rapidly reducing liver steatosis to expand the pool of available organs. This review summarises advances in defatting strategies in experimental and human models of liver steatosis over the last 20 years. (C) 2021 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).

引用

页数：8

共 50 条

[1] Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis
Aoudjehane, Lynda
Gautheron, Jeremie
Le Goff, Wilfried
Goumard, Claire
Gilaizeau, Julia
Nget, Chan Sonavine
Savier, Eric
Atif, Muhammad
Lesnik, Philippe
Morichon, Romain
Chretien, Yves
Calmus, Yvon
Scatton, Olivier
Housset, Chantal
Conti, Filomena
DISEASE MODELS & MECHANISMS, 2020, 13 (04)
[2] Steatosis in Liver Transplantation: Current Limitations and Future Strategies
Linares, Ivan
Hamar, Matyas
Selzner, Nazia
Selzner, Markus
TRANSPLANTATION, 2019, 103 (01) : 78 - 90
[3] An effective defatting cocktail to reduce liver graft steatosis before transplantation
Aoudjehane, L.
Le Goff, W.
Savier, E.
Bonnefoy, P.
Lesnik, P.
Calmus, Y.
Scatton, O.
Housset, C.
Conti, F.
TRANSPLANTATION, 2018, 102 : 58 - 58
[4] An effective defatting cocktail to reduce liver graft steatosis before transplantation
Aoudjehane, L.
Goff, W. L.
Savier, E.
Bonnefoy, P.
Lesnik, P.
Calmus, Y.
Scatton, O.
Housset, C.
Conti, F.
JOURNAL OF HEPATOLOGY, 2018, 68 : S655 - S656
[5] A Review of Defatting Strategies for Non-Alcoholic Fatty Liver Disease
Young, Erin Nicole
Doga, Murat
Watkins, Christine
Bajwa, Amandeep
Eason, James D.
Kuscu, Canan
Kuscu, Cem
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
[6] Defatting the Fatty Liver with Normothermic Perfusion of the Liver Allograft
Perkins, James D.
LIVER TRANSPLANTATION, 2009, 15 (10) : 1366 - 1367
[7] Is Liver Retransplantation Justified in the Current Era?
Llado, Laura
Lopez-Dominguez, Josefina
Ramos, Emilio
Cachero, Alba
Mils, Kristel
Baliellas, Carme
Busquets, Juli
Fabregat, Joan
CIRUGIA ESPANOLA, 2021, 99 (05): : 339 - 345
[8] Contemporary strategies to assess and manage liver donor steatosis: a review
Tien, Christine
Remulla, Daphne
Kwon, Yong
Emamaullee, Juliet
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2021, 26 (05) : 474 - 481
[9] Liver Defatting: An Alternative Approach to Enable Steatotic Liver Transplantation
Nativ, N. I.
Maguire, T. J.
Yarmush, G.
Brasaemle, D. L.
Henry, S. D.
Guarrera, J. V.
Berthiaume, F.
Yarmush, M. L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (12) : 3176 - 3183
[10] Spontaneous liver steatosis in waterfowls: overview on current research and perspectives
Knudsen, Christelle
Bonnefont, Cecile
Fortun-Lamothe, Laurence
Ricaud, Karine
Fernandez, Xavier
INRA PRODUCTIONS ANIMALES, 2018, 31 (02): : 117 - 129

← 1 2 3 4 5 →